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Abstract Metal-catalysed carbenoid chemistry may be exploited in the 
synthesis of diverse range of small molecules from -diazo carbonyl 
compounds. In this paper, three synthetic approaches to -diazo amides 
have been developed, and their scope and limitations have been 
determined.  On the basis of these synthetic studies, recommendations are 
provided to assist the selection of the most appropriate approach for 
specific classes of product.  The availability of practical and efficient 
syntheses of diverse -diazo acetamides is expected to facilitate the 
discovery of many different classes of bioactive small molecules. 
Key words diazo compounds; molecular diversity; carbenoid chemistry 
 
Introduction 
Metal-catalysed carbenoid chemistry can enable the synthesis 
of many different classes of small molecule.1  The diversity of 
the possible products stems from the many different patterns 
of reactivity that are possible, and the scope for both inter- and 
intramolecular reactions.  The diverse patterns of possible 
reactivity include insertion into CH, OH and NH bonds, 
cyclopropanation and ylide formation; some of these processes 
also enable subsequent chemistry such as cycloaddition or 
rearrangement reactions.2-4  Crucially, judicious choice of 
catalyst can provide control over stereochemistry, 
chemoselectivity (e.g. which CH bond in a complex substrate) 
and reaction fate (e.g. which mode of reactivity is favoured).5-10  
The diversity of possible reaction outcomes can enable the 
parallel discovery of diverse bioactive chemotypes.11,12   
We therefore investigated a suite of methods for the synthesis 
of -diazo amides and some related compounds.  These 
methods would ideally enable the efficient synthesis of 
structural-diverse diazo compounds from readily-available 
substrates without the need for purification of any 
intermediates. Overall, the developed methods would ideally 
be complementary, and enable the efficient synthesis of a 
diverse range of substrates. 
 
Results and discussion 
We envisaged three general synthetic approaches to -diazo 
amides 1 (Scheme 1): acylation with an appropriate reagent 
followed by elimination (Approach A); -substitution of -
diazo acetamides 2 (Approach B); and diazo transfer 
(Approach C).  Here, we describe the development, and 
demonstration of the scope and limitations of, practical 
methods for the synthesis of -diazo amides (and some related 
compounds) from readily-available starting materials. 
 
Scheme 1 Overview of synthetic approaches to -diazo amides. 
Approach A: Synthesis by acylation and elimination  
We developed a one-pot synthesis of -diazo amides from 
readily-available amines that was based on an established 
synthesis of -diazoacetic esters.13,14  Glyoxylic acid 4a and 
phenylglyoxylic acid 4b were converted into the corresponding 
toluenesulfonyl hydrazones 5; treatment with thionyl chloride 
in toluene at 90 ºC gave the corresponding acid chlorides 6 
which were used without purification (Scheme 2).  The acid 
chlorides 6a and 6b were orange and yellow amorphous solids 
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respectively, and were stored in vacuo at room temperature for 
a maximum of 12 hr prior to use. 
 
Scheme 2 Synthesis of the acid chlorides 6 which were used without 
purification. 
The acid chloride 6a was exploited in the synthesis of -diazo 
acetamides.  Accordingly, a solution of the acid chloride 6a in 
dichloromethane at 0 ºC was treated with the requisite amine 
and N,N-dimethylaniline under a nitrogen atmosphere; after 2 
hr, triethylamine was added to induce elimination to yield the 
corresponding -diazo acetamide (Scheme 3).  Although DBU 
has been used in syntheses of related products,15 we found 
triethylamine enabled more facile product purification. 
The approach enabled the synthesis of a wide range of -diazo 
acetamides.  In particular, a primary amine (→ 2a), secondary amines (→ 2b-g) and anilines / hetarylamines (→ 2h-m) were 
successful as substrates.  In the case of sterically-hindered 
secondary amines, prolonged coupling and/or elimination was 
necessary to yield the corresponding -diazo acetamides (e.g. 
2f).  The -diazo acetamides 2a-2m were stored at 20 ºC; 
under these conditions, the -diazo acetamide 2h, for example, 
was spectroscopically identical after storage for more than a 
year. 
 
Scheme 3 One-pot synthesis of -diazo acetamides.  Panel A: General synthetic scheme.  Panel B: Structures of the -diazo acetamides prepared.  aProlonged 
reaction (24 hr) between the amine and the  acid chloride was required.  bProlonged reaction time (48 hr) for the elimination was required. 
The acid chloride 6b was exploited in the synthesis of an -
diazo -phenyl acetamide (Scheme 4).  After coupling with 
pyrrolidine (3.3 eq.) in the presence of N,N-dimethylaniline, 
elimination was induced by treatment with a 12 M aqueous 
solution of sodium hydroxide and the phase transfer catalyst 
trioctylmethylammonium chloride (Aliquat® 336; 1 mol%). We 
had investigated the use of trimethylamine and DBU in the 
elimination step with little success, even at elevated 
temperature, before arriving at these optimal conditions.16  We 
demonstrated that, with pyrrolidine, good yields of the 
corresponding -diazo -phenyl acetamide 8 could be obtained. 
 
Scheme 4 One-pot synthesis of a -diazo -phenyl acetamide.  
Approach B: Synthesis by -arylation of the corresponding 
-diazo acetamide 
We developed a method for the -arylation of -diazo 
acetamides 2 (Scheme 5).17  The beneficial effect of Ag2CO3 was 
found following a limited additive screen, and is in line with 
previous studies involving related substrates.17b  In each case, 
Pd(PPh3)4 (5 mol%) and Ag2CO3 (0.5 equiv.) were placed in 
oven-dried glassware under a nitrogen atmosphere, and 
anhydrous toluene, the aryl halide (1 eq.), triethylamine and a 
 
 
solution of the -diazo acetamide 2 (1.3 eq.) in anhydrous 
toluene were added sequentially.  The reactions were stirred at 
room temperature, generally for 4 hr. 
The demonstrated scope of the method is shown in Scheme 5 
(Panel B).  Couplings were successful with a wide range of aryl iodides including iodobenzene (→ 8a) and electron-deficient (e.g. → 9a, 9b and 9e-i) substrates; it was found that couplings 
proceeded most rapidly with electron-deficient substrates.  
Couplings with 5-iodoindole and 4-iodoanisole showed slow 
conversion by TLC and, despite extended (48 hr) reaction times, 
product purification was difficult due to the poor conversions.  
In addition, couplings with aryl bromides were successful with 
electron-deficient substrates (e.g. → 9c and 9d): however, there 
was no evidence of conversion by TLC with bromobenzene, 1-
bromo-3-methoxybenzene, 1-bromo-4-methoxybenzene or 3-
bromopyridine, even with extended reaction times. 
 
Scheme 5 Palladium-catalysed synthesis of -aryl -diazo acetamides.  
Panel A: General synthetic scheme.  Panel B: -Aryl -diazo acetamides 
prepared. aPrepared by method B2, with a 1:1 stoichiometry of diazo to aryl 
iodide.  bPrepared from the corresponding aryl bromide. cPrepared from -
diazo acetamides described in the ESI. 
We also developed a procedure in which the synthesis of the -
diazo acetamide was telescoped with subsequent -arylation 
(Scheme 6).  The telescoped procedure was successful with a 
bridged secondary amine as a substrate (→ 10a).   
 
Scheme 6 Telescoped synthesis of -aryl -diazo acetamides from amines 
and a lactam.  Panel A: General synthetic scheme.  Panel B: -Aryl -diazo 
acetamides prepared. 
 
Approach C: Synthesis by diazo transfer 
The synthesis of -diazo carbonyl compounds by diazo transfer 
has been demonstrated with a range of substrate classes.18,19  
We initially adopted this approach with cyclic 1,3-dicarbonyl 
compounds (Scheme 7).  In our preliminary studies, we had 
found that the use of triethylamine as the base, rather than DBU, 
enabled more facile product purification.  Accordingly, 
triethylamine (1.2 eq.) was added dropwise to a solution of the 
appropriate 1,3-dicarbonyl compound and 4-
acetamidobenzenesulfonyl azide (p-ABSA) (1.5 eq.) in 
anhydrous acetonitrile at 10 ºC, and the reaction then stirred at 
room temperature.  Under these optimal conditions, diazo 
transfer was rapid and was accompanied by precipitation of 4-
acetamidobenzenesulfonamide.20 Efficient diazo transfer was 
observed with a range of 1,3-dicarbonyl compounds including 
1,3-dimethyl barbituric acid (→ 12a), a -keto lactam (→ 12b), a 




Scheme 7 Diazo transfer with cyclic 1,3-dicarbonyl substrates. 
We also investigated the diazo transfer reactions of acyclic -
keto amides (Scheme 8).  A range of structurally diverse -keto 
amide derivatives was prepared by reaction of the appropriate 
nitrogen nucleophile with 2,2,6-trimethyl-1,3-dioxin-4-one (1.1 
eq.) under microwave irradiation (110 °C, max 200 W, max 300 
psi) for 1.5-2 hr.21  Our previous experience11,12 had shown that 
it was possible to telescope the acylation step with a subsequent 
diazo transfer reaction.  Accordingly, treatment of the crude 
acylation products and p-ABSA with triethylamine at 0 ºC 
resulted in smooth diazo transfer. Significantly extended 
reaction times (20-24 hr) were required to yield the diazo 
products 13d, 13f and 13g.  Remarkably, the approach was 
successful with a wide range of nitrogen nucleophiles including anilines (→ 13a-c), a secondary amine (→ 13d), lactams (→ 13e 
and 13f) and an oxazolidinone (→ 13g).  
 
Scheme 8 Synthesis of -diazo -keto amides by diazo transfer.  Panel A: 
General synthetic scheme.  Panel B: -Diazo -keto amides prepared.  
aTelescoped yield. 
The synthesis of -aryl -diazo acetamides 9 by diazo transfer 
was also investigated (Scheme 9).  Although similar -aryl -
diazo acetamides 9 had previously been prepared using 
diphenyl phosphoryl azide (DPPA) and LDA,22 we recognised 
the advantages of p-ABSA in terms of both safety and ease of 
product purification.  We found DBU to be an effective base for 
the transformation.  Accordingly, DBU (2 eq.) was added 
dropwise to a solution of the appropriate -aryl acetamide and 
p-ABSA (1.1 eq.); the reactions were allowed to warm to room 




Scheme 9 Synthesis of -aryl -diazo acetamides by diazo transfer.  Panel A: 
General synthetic scheme.  Panel B: -Aryl -diazo acetamides prepared. 
 
Conclusions 
-Diazo amides have diverse reactivity that can be harnessed in 
the synthesis of a wide range of molecular scaffolds.  Indeed, we 
have previously exploited metal-catalysed reactions of -diazo 
amides in the activity-directed synthesis of diverse androgen 
receptor agonists.  The scope of three synthetic approaches was 
determined, and a summary of our recommendations for which 
approach is most suitable specific classes of product is provided 
in Figure 1. 
 
Figure 1 Scope of the approaches for the synthesis of -diazo amides.  
Approach A: Synthesis by acylation and elimination. Approach B: Synthesis by 
-arylation of the corresponding -diazo acetamide.  Approach C: Synthesis 
by diazo transfer. 
We demonstrated that Approach A (Synthesis by acylation with 
an acid chloride 6 and subsequent elimination) enables the 
synthesis of a wide range of -diazo acetamides.  The value of 
the approach is likely to be very high because of the very wide 
availability of primary amine, secondary amine and aniline 
substrates. 
All three of the approaches can enable the synthesis of -aryl -
diazo amides.  The poor availability of -aryl -keto carboxylic 
acids means that Approach A is likely to be most useful for the 
synthesis of phenyl-substituted analogues.  Approach B 
(Synthesis by Pd-catalysed -arylation of -diazo acetamides), 
on the other hand, enables the introduction of a very broad 
range of (het)aryl substituents.  However, although many aryl 
iodides are competent substrates, the scope of the approach is 
less broad with (more generally available) aryl bromides.  
Finally, Approach C (Synthesis by diazo transfer) is successful 
with a range of -aryl acetamides and enables the synthesis of a 
wide range of -diazo -keto amides.  The approach is 
particularly valuable for -diazo -keto butanamides because 
the required substrates may be easily prepared by acylation of 
the appropriate nitrogen nucleophile (including amines, 
anilines, lactams and oxazolidinones). 
Overall, the availability of practical and efficient approaches for 
the synthesis of -diazo acetamides is expected to facilitate the 
discovery of diverse bioactive small molecules. 
Experimental 
CAUTION: Diazo compounds are potentially explosive and must 
be handled with care. For concentration of material under 
reduced pressure, a maximum water bath temperature of 40 ºC 
was used.  Contact with metal was avoided during syntheses.  
No problems were encountered during our synthetic studies on 
the scales that are described below. 
All non-aqueous reactions were carried out under an 
atmosphere of nitrogen unless otherwise stated and water-
sensitive reactions were performed in anhydrous solvents 
(obtained from a PureSolv MD5 Purification System) in oven-
dried glassware and cooled under nitrogen before use. All other 
solvents and reagents were of analytical grade and used as 
supplied. Ether refers to diethyl ether and petrol refers to 
petroleum spirit (b.p. 40-60 °C) unless otherwise stated. 
Solvents were removed under reduced pressure using an IKA 
RV 10 rotary evaporator. General procedures B2 and C3 are 
included in the Supporting Information. 
Flash column chromatography was carried out using silica gel 
60 (35-70 μm particles) supplied by Merck. Thin layer 
chromatography was carried out using commercially available 
pre-coated aluminium plates (Merck silica gel 60 F254). 
Ultraviolet lamp (λmax = 254 nm) and KMnO4 were used for 
visualisation.  
Accurate mass spectrometry was performed using electrospray 
ionisation on a Bruker MaXis Impact spectrometer.  1H and 13C 
NMR spectra were collected on a Bruker Advance 500, Bruker 
DPX500, DPX400 or DPX300 spectrometer using an internal 
deuterium lock. NMR spectra were recorded at 300 K, unless 
otherwise stated. Chemical shifts are quoted in parts per million 
down field of trimethylsilane and coupling constants (J) are 
given in Hz. Infrared spectra were recorded on a Bruker Alpha 
ATR FR-IR spectrometer; absorptions are reported in 
wavenumber (cm-1). 
General Procedure A: Synthesis of diazo compounds using 
acid chloride reagent 
Toluenesulfonoyl hydrazone, 5a or 5b, (1 eq.) was dissolved in 
anhydrous toluene (25 mL) and purged with N2 for 5 min. 
Thionyl chloride (2 eq.) was added dropwise at RT and the 
solution was stirred vigorously and slowly heated to 90 °C over 
30 min. After 4 hr, the reaction mixture was cooled to RT, the 
 
 
solvent was removed under reduced pressure and the crude 
product was dried under vacuum.   
The crude product (1 eq.) was dissolved in anhydrous CH2Cl2 (3 
mL/mmol) and cooled to 0 °C. A solution of amine (2 eq.) in 
CH2Cl2 (0.5 mL/mmol) and a separate solution of 
dimethylaniline (1 eq.) were added slowly under an N2 
atmosphere. The reaction mixture was stirred overnight before 
NEt3 (5 eq.) was added dropwise over 10 min. The reaction 
mixture was allowed to return to RT gradually and the solution 
was stirred overnight. The reaction mixture was washed with 
aqueous sodium bicarbonate solution and brine solution 
successively. The organic layer was collected, dried (MgSO4), 
filtered and concentrated under reduced pressure to afford the 
crude diazo amide. 
General Procedure B1: 
The appropriate diazo compound (1.3 eq) as a solution in dry 
PhMe, was added to a stirred suspension of the appropriate ArI 
(1 eq), Pd(PPh3)4 (5 mol%), Ag2CO3 (0.5 eq), and NEt3 (1.3 eq) in 
dry PhMe under an N2 atmosphere. The syringe was washed 
twice with dry PhMe and the washings were added to the 
reaction mixture for a final conc. of 0.25 M. After 4 hr, the 
reaction mixture was filtered through a silica plug (2 × ø2 cm) 
eluting with EtOAc (2 × 10 mL). The filtrate was concentrated 
under reduced pressure to give a crude product and was 
purified by flash column chromatography. 
General Procedure C1: Synthesis of diazo compounds by 
diazo transfer 
A solution of dicarbonyl compound (1 eq.) and p-ABSA (1.5 eq.) 
in anhydrous MeCN was cooled to -10 °C. NEt3 (1.2 eq.)  was 
added dropwise over 5-10 min and the mixture was stirred at 
RT under a N2 atmosphere. After 0.5-1 hr (when a solid 
precipitated out of solution and the starting material had been 
consumed by TLC), the solvent was removed under reduced 
pressure and the crude product was dissolved in Et2O (30 
mL/mmol), filtered and the resulting solid rinsed with CH2Cl2 
(30 mL/mmol). The filtrate was concentrated and purified by 
flash column chromatography. 
General Procedure C2: Synthesis of diazo compounds by 
acylation followed by diazo transfer 
2,2,6-Trimethyl-4H-1,3-dioxin-4-one (1.1 eq.) was added to a 
solution of aniline (1 eq.) in toluene and the mixture was reacted under μW irradiation (110 °C, max 200 W, max 300 psi). 
After 1.5-2 hr, the solvent was removed under reduced 
pressure. p-ABSA (1.5 eq.) was added followed by anhydrous 
MeCN and the solution was cooled to 0 °C. NEt3 (1.2 eq.)  was 
added dropwise over 5-10 min and the mixture was stirred at 
RT under an N2 atmosphere. After 4 hr, the solvent was removed 
under reduced pressure and the crude product purified by flash 
column chromatography. 
2-(4-Methylbenzenesulfonamido)imino acetic acid, 5a 
Glyoxylic acid (0.08 mol, 7.4 g) and p-toluenesulfonylhydrazide 
(0.05 mol, 10.0 g) were dissolved in THF (70 mL) and the 
mixture stirred vigorously at RT for 24 hr. The solvent was 
removed under reduced pressure and the resulting residue was 
triturated with cold water. The solid was air-dried for two days 
to attain the crude product. The crude product was 
recrystallised in EtOAc to afford pure product 5a as a white 
amorphous solid (12.80 g, 99%); 1H (400 MHz, Acetone-d6): δ = 
11.01 (1H, s, OH), 7.82 (2H, d, J 8.0, phenyl 3-H and 5-H), 7.43 
(2H, d, J 8.0, phenyl 2-H and 6-H), 7.32 (1H, s, 2-H) and 2.42 (3H, 
s, Methyl); δc (100 MHz, Acetone-d6) 206.3, 163.8, 145.3, 137.3, 
130.6, 128.5 and 21.4; IR νmax (neat)/cm-1 3170, 2892, 1695 and 
1595; HRMS (ESI) C9H10N2NaO4S requires [M+Na]+, calculated 
265.0254, found 265.0252. 
2-Diazo-N-(prop-2-en-1-yl)acetamide, 2a 
By general procedure A, 6a (3 mmol, 780 mg) with allylamine (6 
mmol, 448 µL) gave a crude material and was purified by 
column chromatography eluting with CH2Cl2–Et2O (9:1) to yield 
the diazo acetamide 2a as a yellow oil (298 mg, 79%); Rf 0.40 
(Et2O); IR νmax/cm-1 (film) 3291, 3089, 2925, 2103, 1618 and 
1542; 1H (400 MHz, Acetone-d6) δ = 6.91 (1H, br s, NH), 5.85 
(1H, ddt, J 17.2, 10.6 and 5.4, propenyl 2-H), 5.72 (1H, s, 
diazoacetamide 2-H1), 5.16 (1H, dq. J 17.2 and 1.6, propenyl 3-H 
trans), 5.04 (1H, dq, J 10.3 and 1.6, propenyl 3-H cis) and 3.86 
(2H, tt, J 5.7 and 1.6, propenyl 1-H); 13C (100 MHz, Acetone-d6): δ = 165.7, 136.4, 115.5, 46.8 and 42.5; HRMS (ESI): 
C10H14N6O2Na requires [2M+Na]+, calculated 273.1076 found 
273.1069. 
2-Diazo-1-(morpholin-4-yl)ethenone, 2b 
By general procedure A, 6a (1.5 mmol, 390 mg) and morpholine 
(3 mmol, 260 µL) gave a crude material and was purified using 
column chromatography eluting with CH2Cl2–Et2O (9:1) to yield 
the diazo acetamide 2d as a yellow oil (193 mg, 83%); Rf 0.24 
(Et2O); IR νmax/cm-1 (film) 3056, 2973, 2036, 1647, 1488;  1H 
(300 MHz, Acetone-d6): δ = 5.34 (1H, s, diazo acetamide 2-H1), 
3.30 (4H, app br m, morpholine 2-HAB and 6-HAB) and 1.89 
(4H, app br s, morpholine 3-HAB and 5-HAB); 13C (75 MHz, 
Acetone-d6): δ = 164.0, 46.4, 26.5 and 25.2. HRMS (ESI): 
C6H10N3O2 requires [M+H]+, calculated 156.0773, found 
156.0768. 
2‐Diazo‐1‐(3‐phenylpyrrolidin‐1‐yl)ethan‐1‐one, 2c 
By general procedure A, 6a (3.4 mmol, 884 mg) and 3-phenyl 
pyrrolidine (6.8 mmol, 1 g) gave a crude material and was 
purified using column chromatography eluting with CH2Cl2 for 
three column volumes then CH2Cl2–Et2O (9:1) to yield the diazo 
acetamide 2e as a bright orange oil (574 mg, 78%); Rf = 0.32 
(Et2O); IR νmax (CH2Cl2 film)/cm-1 2095, 1600, 1417, 1166; 1H 
(500 MHz, CD2Cl2): δ = 7.33 (2H, dd, J 7.0, 8.0), 7.26 (3H, m), 4.89 
(1H, s), 4.02-3.62 (2H, m), 2.35-2.29 (1H, broad m), 2.07-2.01 
(1H, broad m); 13C (125 MHz, CD2Cl2): δ = 163.8 (rot-A/B), 141.4 
(rot-B), 141.1 (rot- A), 129.9 (rot-B), 129.8 (rot-A), 128.7 (rot-
A/B), 127.14 (rot-A/B), 52.5 (rot-A/B), 52.3 (rot-A/B), 46.2 
(rot-A), 45.8 (rot-B), 44.6 (rot-A), 42.9 (rot-B), 33.4 (rot-A), 33.1 
(rot-B); HRMS (ESI): C12H13N3O requires [M+H]+, calculated 
216.1137, found 216.1127. 
2-Diazo-1-(pyrrolidin-1-yl)ethenone, 2d  
By general procedure A, 6a (1.5 mmol, 390 mg) and pyrrolidine 
(3 mmol, 246 µL) gave a crude material and was purified using 
column chromatography eluting with CH2Cl2–Et2O (9:1) to yield 
the diazo acetamide 2f as a yellow oil (132 mg, 63%); Rf = 0.20 
(Et2O); IR νmax (neat)/cm-1 3063, 2974, 2875, 2096, 1594 and 
1425; 1H (400 MHz, CDCl3): δ = 4.80 (1H, s, diazoacetamide 2-H), 
3.52 (2H, app br s, pyr 2-HA and 5-HA), 3.20 (2H, app br s, pyr 2-
HB and 5-HB), ), 1.94 (2H, app br s, pyr 3-HA and 4-HA) and 1.87 
(2H, app br s, pyr 3-HB and 4-HB); 13C (100 MHz, CDCl3): δ = 
163.2, 63.2, 45.5, 17.8 and 14.8; HRMS (ESI): C6H9N3O requires 




By general procedure A, 6a (4.3 mmol, 1.12 g) and N-methyl-N-
tetrahydro-2H-pyran-4-ylamine (4.3 mmol, 495 mg) gave a 
crude material and was purified using column chromatography 
eluting with CH2Cl2–Et2O (9:1) for 3 column volumes then Et2O 
to afford the diazo acetamide 2h as a bright orange oil (708 mg, 
90%); Rf = 0.10 (Et2O); IR νmax (CH2Cl2 film)/cm-1 2098, 1600, 
1410, 1256, 1144 and 1086; 1H (500 MHz, CD2Cl2): δ = 5.01 (1H, 
s), 3.98 (1H, d, J 4.6), 3.96 (1H, d, J 4.6), 3.44 (2H, t, J 11.4), 2.7 
(3H, s), 1.77-1.73 (3H, m) and 1.55-1.52 (2H, m). 13C (125 MHz, 
CD2Cl2): δ = 165.9 (rot-A/B), 130.0 (rot-A), 126.6 (rot-B), 104.6 
(rot-A/B), 67.8 (rot-A/B), 46.8 (rot-A/B) and 30.7 (rot-A/B); 
HRMS (ESI): C8H13N3O2 requires [M+Na]+, calculated 206.0905, 
found 206.0892. 
2-Diazo-1-(2-isopropyl-2,5-dihydropyrrol-1-yl)ethenone, 2f 
By general procedure A, 6a (6 mmol, 1.56 g) and 2-isopropyl-
2,5-dihydro-1H-pyrrole (12 mmol, 1.55 mL) gave a crude 
material and was purified by flash column chromatography 
eluting with Petrol–EtOAc (8:2) to give the diazo acetamide 2i as 
a yellow oil (0.225 g, 21%); Rf = 0.31 (Petrol−EtOAc, 8:2); IR νmax 
(film)/cm-1 2961, 2100, 1700, 1596 and 1412; 1H (300 MHz, 
Acetone-d6): δ = 5.93 (1H, m, dihydropyrrolyl 4–H), 5.83 (1H, m, 
dihydropyrrolyl 3–H), 5.40 (1H, s, 2–H), 4.71 (1H, m, 
dihydropyrrolyl 2–H), 4.06 (2H, m, dihydropyrrolyl 5–H), 2.49 
(1H, m, isopropyl–H), 0.92 (3H, d, J 6.7, isopropyl–Ha) and 0.69 
(3H, d, J 6.7, isopropyl–Hb); 13C (75 MHz, Acetone-d6): δ = 164.5, 
127.9, 126.8, 70.6, 54.9, 46.8, 30.6, 19.2 and 16.0; HRMS (ESI) 




By general procedure A, 6a (6.2 mmol, 1.61 g) and 1-isopropyl-
1H,2H,3H,4H,9H-pyrido[3,4-b]indole (12.4 mmol, 2.66 g)  gave a 
crude material and was purified by flash column 
chromatography, eluting with CH2Cl2−MeOH (99:1) to give the 
diazo acetamide 2j as a yellow amorphous solid (0.457 g, 26%); 
IR νmax (film)/cm-1 3194, 2967, 2103, 1580, 1467, 1428, 1349; 
1H (300 MHz, CD2Cl2): δ = 7.48 (1H, d, J 7.5, indolyl 5–H), 7.36 
(1H, d, J 7.5, indolyl 8–H), 7.14 (2H, m, indolyl 6–H and 7–H), 
5.58 (1H, d, J 14.4, indolyl 1–H), 5.25 (1H, s, 2–H), 3.50 (2H, br 
m, indolyl 3–H), 2.82 (2H, m, indolyl 4–H), 2.14 (1H, dt, J 6.7, 6.7 
and 14.4, isopropyl–H), 1.15 (3H, d, J 6.7, isopropyl–Ha), 0.99 
(3H, d, J 6.7, isopropyl–Hb); 13C (126 MHz, methylene chloride-
d2): δ = 166.1, 136.7, 134.7, 127.1, 121.9, 119.5, 118.2, 111.6, 
107.7, 56.2, 47.1, 41.2, 33.7, 22.3, 20.2, 20.1; Rf 0.39 
(CH2Cl2−MeOH, 99:1); HRMS (ESI) C16H18N2O requires [M-N2], 
calculated 254.1414, found 254.1486. 
4-(Diazoacetyl)-1-thiomorpholine-1,1-dione, 2h 
By general procedure A, 6a (1.5 mmol, 390 mg) and 
thiomorpholine-1,1-dioxide (3 mmol, 405 mg), gave a crude 
material and was purified using column chromatography eluting 
with CH2Cl2–Et2O (9:1) to yield the diazo acetamide 2k as a 
yellow solid (295 mg, 97%); Rf 0.34 (Pentane–Et2O, 1:1); 1H 
(400 MHz, Acetone-d6): δ = 5.88 (1H, s, diazoacetamide 2-H), 
3.92 (4H, m, 2-HAB and 6-HAB) and 3.10 (4H, m, 3-HAB and 5-HAB); 
13C (100 MHz, Acetone-d6): δ = 165.6, 52.42, 46.9 and 43.2; 
HRMS found MNa+: 226.0255 (C6H9N3O3SNa requires MNa, 
226.0262). 
2-Diazo-N-methyl-N-phenylacetamide, 2i 
By general procedure A, 6a (3 mmol, 780 mg) and N-
methylaniline (6 mmol, 650 µL) gave a crude material and was 
purified using column chromatography eluting with CH2Cl2–
Et2O (9:1) to yield the diazo acetamide 2l as an orange oil (419 
mg, 80%); Rf = 0.45 (Pentane–Et2O, 1:1); IR νmax (neat)/cm-1 
3118, 3061, 2934, 2101 and 1621; 1H (400 MHz, (CD3)2CO): δ = 
7.48-7.28 (2H, m, Ar 3-H and 5-H), 7.28-7.18 (1H, m, Ar 4-H), 
7.20-7.16 (2H, m, Ar 2zz-H and 6-H), 4.81 (1H, s, diazoacetamide 
2-H) and 3.12 (3H, s, NMe); 13C (100 MHz, (CD3)2CO): δ = 165.7, 
144.4, 130.5, 128.4, 128.2, 47.4 and 37.1; Spectroscopic data 
matches literature 23 
N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-diazo-N-
methylacetamide, 2j 
By general procedure A, 6a (1 mmol, 260 mg) and N-methyl-4-
cyano-3-trifluoromethylaniline (2 mmol, 400 mg), a crude 
material was obtained and purified using column 
chromatography eluting with CH2Cl2–Et2O (9:1) to yield the 
diazo acetamide 2o as a yellow solid (212 mg, 79%); Rf 0.43 
(Et2O); 1H (400 MHz, (CD3)2CO): δ = 8.11 (1H, d, J 8.4, Ar 5-H), 
8.05 (1H, d, J 2.0, Ar 2-H), 7.89 (1H, dd, J 8.4 and 2.0, Ar 6-H), 
5.56 (1H, s, diazoacetamide 2-H), 3.40 (3H, s, NMe); 13C (101 
MHz, (CD3)2CO): δ = 166.4, 148.9, 137.0, 130.4, 125.2, 125.1, 
116.0, 48.7, 36.8; IR νmax (neat)/cm-1 3091, 2231, 2108, 1605, 
1377; HRMS (ESI): C11H8F3N4O requires [M+H]+, calculated 
269.0690, found 269.0619. Spectroscopic data matches 
literature 12 
2‐Diazo‐N‐phenylacetamide, 2k 
By general procedure A, 6a (3 mmol, 780 mg) and aniline (6 
mmol, 545 µL), a crude material was obtained and purified 
using column chromatography eluting with CH2Cl2–Et2O (9:1) to 
yield the diazo acetamide 2p as an orange solid (682 mg, 71%); 
Rf = 0.52 (CH2Cl2–Et2O, 9:1); 1H (400 MHz, Acetone-d6): δ = 8.88 
(1H, s), 7.60 (2H, m), 7.27 (2H, m), 7.02 (1H, m), 5.40 (1H, s); 13C 
(100 MHz, Acetone-d6): δ = 164.4, 140.7, 129.6, 123.7, 119.7, 
119.6, 48.6; IR νmax (CH2Cl2 film)/cm-1 3085, 2093 (diazo), 1631, 
1600, 1548, 1442, 1369; HRMS (ESI): C8H7N3O requires [M+H]+, 
calculated 162.0667, found 162.0655. Spectroscopic data 
matches literature 24 
2‐Diazo‐N‐(3‐methyl‐1,2‐oxazol‐5‐yl)propenamide, 2l 
By general procedure A, 6a (4.3 mmol, 1.12 g) and 5-amino-3-
methylisoxazole (4.3 mmol, 422 mg), a crude material was 
obtained and purified using column chromatography eluting 
with CH2Cl2–Et2O (9:1) to yield the diazo acetamide 2q as a 
bright orange oil (170 mg, 24%); 1H (500 MHz, Acetone-d6): δ = 
10.17 (1H, s), 6.13 (1H, s), 5.99 (1H, s), 2.19 (3H, s). 13C (125 
MHz, Acetone-d6): δ = 162.7 (rot-A), 162.6 (rot-B), 162.2 (rot-A), 
162.1 (rot-B), 161.6 (rot-A/B), 88.7 (rot-A), 88.6 (rot-B), 49.3 
(rot-A/B), 11.6 (rot-A/B); IR νmax (CH2Cl2 film)/cm-1 3205, 2109 
(diazo), 1648, 1551, 1381, 1364, 1197, 1155; Rf 0.49 (Et2O); 




By general procedure A1, 6a (2.7 mmol, 700 mg) and aniline S3 
(500 mg, 1.9 mmol) gave a crude material which was purified 
using column chromatography eluting with pentane–Et2O (1:1) 
to yield the diazo acetamide 2r as a yellow solid (333 mg, 50%); 
1H (500 MHz, Acetone-d6): δ = 8.72 (1H, br s, NH), 7.42 (1H, d, J 
2.6, 2–H), 7.37 (1H, dd, J 8.6 and 2.6, 6–H), 6.77 (2H, d, J 8.6, 5–
 
 
H), 5.36 (1H, s, diazoacetamide 2–H), 3.33 (1H, hep, J 6.9, 
propan-2-yl 2–H), 1.18 (6H, d, J 6.9 propan-2-yl 1–H and 3–H), 
1.04 (9H, s, tert-butyl–H), 0.25 (6H, s, dimethyl–H); 13C (125 
MHz, Acetone-d6): δ = 164.1, 149.2, 139.8, 134.7, 119.3, 118.4, 
118.3, 48.4, 27.5, 26.3, 23.3, 19.0, -3.9; Rf 0.2 (Pentane–Et2O, 
1:1); IR νmax (film)/cm-1 3279, 3085, 2959, 2929, 2886, 2858, 
2101, 1622, 1602, 1550, 1490, 1471; HRMS (ESI) C17H28N3O2Si 
requires [M+H]+, calculated 334.1951, found 334.1949. 
N‐{4‐[(tert‐Butyldimethylsilyl)oxy]‐3‐(propan‐2‐yl)phenyl}‐
2‐diazo‐N‐methyl-acetamide, 2n 
By general procedure A1, 6a (2.7 mmol, 700 mg) and aniline S4 
(1.8 mmol, 500 mg) gave a crude material which was purified 
using column chromatography eluting with pentane–Et2O (8:2) 
to yield the diazo acetamide 2s as a yellow solid (500 mg, 79%); 
1H (500 MHz, Acetone-d6): δ = 7.15 (1H, d, J 2.7, 2–H), 7.00 (1H, 
dd, J 8.5 and 2.7, 6–H), 6.91 (1H, d, J 8.5, 5–H), 4.77 (1H, s, 
diazoacetamide 2–H), 3.35 (1H, hept, J 6.9, propan-2-yl 2–H), 
3.21 (3H, s, methyl–H), 1.21 (6H, d, J 6.9, propan-2-yl 1–H and 3–
H), 1.05 (9H, s, tert-butyl–H), 0.29 (6H, s, dimethyl–H); 13C (126 
MHz, Acetone-d6): δ = 166.0, 153.0, 141.3, 137.8, 126.4, 126.4, 
120.0, 47.3, 37.4, 27.7, 26.3, 23.2, 19.0, -3.9; Rf 0.4 (Pentane–
Et2O, 8:2); IR νmax (film)/cm-1 3280, 3085, 2959, 2930, 2859, 
2101, 1622, 1602, 1549, 1491; HRMS (ESI) C18H30N3O2Si 
requires [M+H]+, calculated 348.2107, found 348.2112. 
2-Diazo-2-phenyl-1-(pyrrolidin-1-yl)ethenone, 8 
By general procedure A, 6b (1.5 mmol, 500 mg) and pyrrolidine 
(3 mmol, 250 µL) gave a crude material which was purified 
using column chromatography eluting with CH2Cl2–Et2O (9:1) to 
yield the diazo acetamide 8 as a yellow oil (274 mg, 63%); Rf 
0.34 (Pentane–Et2O, 1:1); 1H (400 MHz, (CD3)2CO): δ = 7.97 (2H, 
m, Ar 2-H and 6H), 7.74 (1H, tt, J 7.2 and 1.2, Ar 4-H), 7.61 (2H, 
app t, J 7.2  Ar 3-H and 5-H), 3.74 (4H, m, pyr 2-HAB and 5-HAB), 
3.61 (2H, m, pyr 3-HAB), 3.38 (2H, m, pyr 4-HAB); 13C (101 MHz, 
(CD3)2CO): δ = 165.2, 134.7, 129.4, 129.1, 128.6, 127.3, 66.4, 
66.2, 46.0, 41.2; IR νmax (neat)/cm-1 2925, 2101, 1646. 
2-[4-Cyano-3-(trifluoromethyl)phenyl]-2-diazo-N,N-
dipropylacetamide, 9a 
By general procedure B2 (1 mmol scale), S11 (1 mmol, 169 mg) 
and 4-iodo-2-(trifluoromethyl)benzonitrile (1 mmol, 297 mg) 
gave a crude material which was purified using column 
chromatography eluting with CH2Cl2–Et2O (19:1) to yield the 
diazo acetamide 9a as a red solid (277 mg, 82%); Rf 0.52 
(Pentane–Et2O, 1:1); 1H (400 MHz, (CD3)2CO): δ = 8.00 (1H, d, J 
8.4, Ar 5-H), 7.86 (1H, d, J 1.9, Ar 2-H), 7.68 (1H, dd, J 8.4 and 2.0, 
Ar 6-H), 3.43-3.35 (4h, m,  propyl 1-H), 1.65 (4H, sx, J 7.4, propyl 
2-H), 0.89 (6H, t, J 7.4, propyl 3-H); 13C (101 MHz, (CD3)2CO): 
162.3, 136.2, 135.2, 132.2, 126.2, 124.1, 121.0, 115.5, 104.1, 
48.9, 20.8, 10.5 (1 signal missing); IR νmax (neat)/cm-1 2960, 
2937, 2878, 2228, 2068, 1632 and 1434; HRMS (ESI): 





By general procedure B2 (0.5 mmol scale), 2f (0.5 mmol, 70mg) 
and 4-iodo-2-(trifluoromethyl)benzonitrile (0.5 mmol, 149 mg) 
gave a crude material which was purified using column 
chromatography eluting with CH2Cl2–Et2O (9:1) to yield the 
diazo acetamide 9b as a red solid (119 mg, 77%); Rf 0.33 (Et2O); 
1H (400 MHz, (CD3)2CO): 8.09 (1H, d, J 2.0, Ar 3-H), 7.99 (1H, d, J 
8.4, Ar 6-H), 7.77 (1H, dd, J 8.4 2.0, Ar 5-H), 3.52 (4H, m, 2-HAB, 
5-HAB), 2.00 – 1.81 (4H, m, 3-HAB, 4-HAB); 13C (101 MHz, 
(CD3)2CO): δ = 161.5, 136.9, 135.9, 132.5, 127.2, 125.5, 122.3, 
121.9, 116.5, 105.0, 48.3, 25.9 (1 signal missing); IR νmax 
(neat)/cm-1 2899, 2848, 2193, 2045, 1675 and 1390; HRMS 
found MNa+: 331.0776 (C14H11F3N4ONa requires MNa, 331.0783) 
2-Diazo-2-(4-nitrophenyl)-1-(pyrrolidin-1-yl)ethenone, 9c 
By general procedure B1 (1.53 mmol scale), 2f (2 mmol, 280 
mg) and 4-iodo-1-nitrobenzene (1.53 mmol, 310 mg) gave a 
crude material which was purified using column 
chromatography eluting with CH2Cl2–Et2O (9:1) to yield the 
diazo acetamide 9c as a dark orange solid (226 mg, 57%); 1H 
(501 MHz, DMSO-d6): δ = 7.77-7.74 (2 H, app m, J 9.1 and 2.0, 
phenyl 3–H and 5–H), 7.14-7.11 (2 H, app m, J 9.1 and 2.0, 
phenyl 2–H and 6–H), 2.97 (4 H, app m, pyrrolidinyl 2–Hab and 
5–Hab), 1.42 (4 H, m, pyrrolidinyl 3–Hab and 4–Hab); 13C (126 
MHz, DMSO-d6): δ = 160.93, 144.40, 136.97, 131.52, 130.73, 
64.05, 47.88, 25.31; Rf  0.6 (CH2Cl2–Et2O, 9:1); IR νmax (neat)/cm-
1 2062, 1625, 1525, 1391, 1346, 1235, 1170, 826; HRMS Found 
MNa+:283.0800 (C12H12N4NaO3 requires MNa, 283.0807). 
4-[1-Diazo-2-oxo-2-(pyrrolidin-1-yl)ethyl]-3-
methylbenzonitrile, 9d 
By general procedure B1 (1 mmol scale), 2f (1.3 mmol, 180 mg) 
and 4-bromo-3-methylbenzonitrile (1 mmol, 196 mg) gave a 
crude material which was purified by column chromatography 
eluting with CH2Cl2–Et2O (9:1) to yield the diazo acetamide 9d 
as a pale yellow solid (119 mg, 47%); 1H (501 MHz, Acetone-d6): δ = 7.78 (1 H, d, J 8, 5–H), 7.66 (1 H, app s, 2–H), 7.63 (1 H, app d, 
J 8, 5–H), 3.40 (4 H, m, pyrrolidinyl 2–Hab and 5–Hab), 2.48 (3 H, 
s, 3-methyl–H3), 1.84 (4 H, m, pyrrolidinyl 3–Hab and 4–Hab); 13C 
(126 MHz, Acetone-d6): δ = 192.76, 164.07, 141.16, 136.39, 
135.29, 132.13, 129.67, 117.63, 115.90, 46.41, 45.17, 25.67, 
23.63, 19.82; Rf 0.46 (CH2Cl2–Et2O, 9:1); IR νmax (neat)/cm-1 
2231, 1685, 1637, 1444, 1220, 1012, 848, 708; HRMS (ESI) 




By general procedure B1 (0.83 mmol scale), 2f (1.1 mmol, 153 
mg) and 4-iodo-1-methyl-2-nitrobenzene (0.83 mmol, 218 mg) 
gave a crude material which was purified by column 
chromatography eluting with CH2Cl2–Et2O (9:1) to yield the 
diazo acetamide 9e as an orange solid (118 mg, 48%); 1H (501 
MHz, Acetone-d6): δ = 7.94 (1 H, d, J 2.0, 2–H), 7.37 (1 H, dd, J 8.2 
and 2.0, 5–H), 7.3 (1 H, d, J 8.2, 56H), 3.33 (4 H, m, pyrrolidinyl 
2–Hab and 5–Hab), 2.36 (3 H, s, 3-methyl–H3), 1.79 (4 H, m, 
pyrrolidinyl 3–Hab and 4–Hab); 13C (126 MHz, Acetone-d6): δ = 
161.77, 149.79 133.00, 129.27 127.91, 119.87, 47.47, 25.10, 
18.74; Rf 0.55 (CH2Cl2–Et2O, 9:1); IR νmax (neat)/cm-1 2066, 
1627, 1590, 1510, 1393, 1337, 1111, 850, 751; HRMS Found 
MNa+:297.0960 (C13H14N4NaO3 requires MH, 297.0963). 
2-Diazo-2-(3,4-dichlorophenyl)-1-(pyrrolidin-1-
yl)ethenone, 9f 
By general procedure B1 (1 mmol scale), 2f (1.3 mmol, 180 mg) 
and 1,2-dichloro-4-iodobenzene (1 mmol, 273 mg) gave a crude 
material which was purified by column chromatography eluting 
with CH2Cl2–Et2O (9:1) to yield the diazo acetamide 9f as an 
orange oil (96 mg, 34%); 1H (501 MHz, Acetone-d6): δ = 7.70 (1 
 
 
H, app d, J 2.20, 5–H), 7.56-7.53 (1 H, app m, 2–H), 7.31 (1 H, m, 
6–H), 3.46 (4 H, app m, pyrrolidinyl 2–Hab and 5–Hab), 1.93 (4 H, 
m, pyrrolidinyl 3–Hab and 4–Hab); 13C (126 MHz, Acetone-d6): δ = 
161.65, 132.16, 130.57, 129.35, 127.76, 125.84, 123.70, 54.08, 
47.43, 25.06; Rf 0.51 (CH2Cl2–Et2O, 9:1); IR νmax (film)/cm-1 
2062, 1626, 1474, 1388, 1338, 1135, 1027, 735; HRMS Found 
MNa+:306.0170 (C12H11Cl2N3NaO requires MNa, 306.0177). 
N-[(4-Chlorophenyl)methyl]-2-diazo-N-methyl-2-[4-
(trifluoromethyl)phenyl]acetamide, 9g 
By general procedure B1 (3 mmol scale), S8 (3.9 mmol, 872 mg) 
and 4-trifluoromethyl-iodobenzene (3 mmol, 440 μl) gave a 
crude material which was purified by column chromatography 
eluting with CH2Cl2–Et2O (9:1) to yield aryl diazo acetamide 9g 
as a bright orange oil (535 mg, 1.46 mmol, 49%); Rf 0.5 (CH2Cl2–
Et2O, 9:1); 1H NMR (400 Hz, CDCl3):   = 7.54 (2H, d, J = 8.4 Hz, 
Ar(F)-3H), 7.29-7.25 (4H, m, Ar(F)-2H and Ar(Cl)-3H), 7.16 (2H, 
d, J = 8.5 Hz, Ar(Cl)-2H), 4.51 (2H, s, ArCH2), 2.80 (3H, s, N-CH3); 
13C NMR (125 Hz, CDCl3):  = 164.5, 134.9, 133.8, 131.9, 129.4, 
129.1, 126.1 (q, J3F-C = 4 Hz), 123.9, 62.7 (verified through HMBC 
spectrum), 52.1, 36.1 (2 signals missing); IR: νmax/cm-1 (film) 
3096, 2107, 1632, 1208; HRMS: C17H13ClF3N3ONa (MNa) 
Requires: 390.0591, Found: 390.0586. 
2-Diazo-N,N-diethyl-2-[4-
(trifluoromethyl)phenyl]acetamide, 9h 
By general procedure B1 (2 mmol scale), S9 (2.6 mmol, 366 mg) 
and 4-trifluoromethyl-iodobenzene (2 mmol, 294 μl) gave a 
crude material which was purified by column chromatography 
eluting with CH2Cl2–Et2O (9:1) to yield the aryl diazo acetamide 
9h as a bright orange oil (264 mg, 0.97 mmol, 47%); Rf 0.45 
(CH2Cl2–Et2O, 9:1); 1H NMR (400 Hz, CDCl3):  7.52 (2H, d, J = 
8.4 Hz, Ar-3H), 7.24 (2H, d, J = 8.4 Hz, Ar-2H), 3.34 (4H, q, J = 7.1 
Hz, Et-1H), 1.13 (6H, t, J = 7.1 Hz, Et-2H); 13C NMR (125 Hz, 
CDCl3):  = 163.6, 132.4, 127.6 (q, J2F-C = 29 Hz), 125.9 (q, J3F-C = 4 
Hz), 125.5 (q, J1F-C = 277 Hz), 61.5, 41.9, 13.2 (2 signals missing); 
IR νmax/cm-1 (film) 3083, 2111, 1644, 1204; HRMS: C13H15F3NO 
(MH-N2) Requires: 258.1100, Found: 258.1102.
2-Diazo-N,N-diethyl-2-(4-nitrophenyl)acetamide, 9i 
By general procedure B1 (2 mmol scale), S9 (2.6 mmol, 366 mg) 
and 4-nitro-iodobenzene (2 mmol, 498 mg) gave a crude 
material which was purified by column chromatography eluting 
with CH2Cl2–Et2O (9:1) to yield the aryl diazo acetamide 9i as a 
bright orange amorphous solid (277 mg, 1.1 mmol, 53%); Rf 
0.45 (CH2Cl2–Et2O, 9:1); 1H NMR (400 Hz, CDCl3): 8.13 (2H, d, 
J = 9.1 Hz, Ar-3H), 7. 27 (2H, d, J = 9.1 Hz, Ar-2H), 3.36 (4H, q, J = 
7.1 Hz, Et-1H), 1.16 (6H, t, J = 7.1 Hz, Et-2H); 13C NMR (125 Hz, 
CDCl3)  = 162.7, 144.8, 136.3, 124.4, 123.3, 62.2 (verified 
through HMBC spectrum), 42.0, 13.2; IR νmax/cm-1 (film) 3029, 
2119, 1659, 1503;  HRMS: C12H15N2O3 (MH-N2) Requires: 
235.1077, Found: 235.1074. 
N-[2-(4-Chlorophenyl)ethyl]-2-diazo-N-methyl-2-[4-
(trifluoromethyl)phenyl]acetamide, 9j 
By general procedure B1 (4 mmol scale), S10 (5.2 mmol, 1.23g) 
and 4-trifluoromethyl-iodobenzene (4 mmol, 589 μL) gave a 
crude material which was purified by column chromatography 
eluting with CH2Cl2–Et2O (9:1) to yield the aryl diazo acetamide 
9j as a bright orange oil (769 mg, 2.01 mmol, 50%); Rf 0.52 
(CH2Cl2–Et2O, 9:1); 1H NMR (400 Hz, CDCl3);  = 7.49 (2H, d, J = 
8.3 Hz, Ar(F)-3H), 7.20 (2H, d, J = 8.3 Hz, Ar(F)-2H), 7.09 (2H, 
2H, d, J = 8.1 Hz, Ar(Cl)-3H), 7.06 (2H, d, J = 8.1 Hz, Ar(Cl)-2H), 
3.57 (2H, t, J = 7.3 Hz, ArCH2CH2), 2.86-2.81 (5H, m, ArCH2CH2, 
and N-CH3); 13C NMR (125 Hz, CDCl3)  164.4, 136.7, 132.6, 
131.9, 130.1, 128.8, 127.6 (q, J2F-C = 29 Hz), 125.9 (q, J3F-C = 3 Hz), 
123.8, 62.4 (verified through HMBC spectrum), 50.7, 36.6, 33.1; 
IR νmax/cm-1 (film) 3087, 2113, 1652, 1199;  HRMS: 




By telescoping general procedures A and B2  (0.25 mmol scale), 
a crude material was obtained and purified using column 
chromatography eluting with CH2Cl2–Et2O (9:1) to yield the 
diazoacetamide 10a as a yellow oil (49 mg, 44%); Rf 0.10 (Et2O); 
1H (400 MHz, (CD3)2CO): δ = 7.89 (2H, m, Ar 5-H, 2-H), 7.67 (1H, 
m, Ar 6-H), 4.29 (2H, app s, 3-H, 6-H), 3.75 (2H, m, 2-HA, 7-HA), 
2.96 (2H, m, 2-HB, 7-HB), 1.81 (2H, m, 4-HA, 5-HA),1.63 ((2H, m, 
4-HB, 5-HB), 1H), 1.32 (3H, s, tert-butyl); 13C (101 MHz, 
(CD3)2CO): δ = 163.3, 156.0, 136.4, 136.2, 127.5, 122.3, 116.4, 
105.4, 80.1, 55.4, 27.3; HRMS found MNa+: 472.1564 
(C21H22F3N5O3Na requires MNa, 472.1572). 
5-Diazo-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione, 
12a 
By general procedure C1, to 1,3-dimethylpyrimidine-
2,4,6(1H,3H,5H)-trione (6.4 mmol, 1.00 g) and p-ABSA (9.6 
mmol, 2.30 g) in MeCN (0.12 M, 54 mL) was added NEt3 (1.10 
mL, 7.68 mmol) dropwise at -10 °C and allowed to react at room 
temperature for 30 min. The crude material was purified by 
column chromatography eluting with EtOAc–petrol (1:1) to give 
the diazo compound as a pale yellow amorphous solid (1.025 g, 
88%); 1H (501 MHz, methylene chloride-d2): δ = 3.27 (6 H, s, 
dimethyl); 13C (126 MHz, methylene chloride-d2): δ = 158.53, 
150.88, 71.93, 28.60; Rf 0.55 (EtOAc–petrol, 1:1); IR νmax 
(neat)/cm-1 2155, 1710, 1638, 1468, 1415, 1372, 1291, 1245, 
1066; HRMS (ESI) Molecular ion not found. Spectroscopic data 
matches literature.25 
3-Diazo-2,4-piperidinedione, 12b 
By general procedure C1, to 2,4-piperidinedione (4.42 mmol, 
500 mg) and p-ABSA (6.63 mmol,1.59 g) in MeCN (0.12 M, 37 
mL) was added NEt3 (0.73 mL, 5.30 mmol) dropwise at -10 °C 
and allowed to react at room temperature for 30 min. The crude 
material was purified by column chromatography eluting with 
CH2Cl2–MeOH (9:1). The product was further purified by column 
chromatography eluting with Et2O to give the diazo compound 
as a colourless amorphous solid (204 mg, 33%); 1H (501 MHz, 
methylene chloride-d2): δ = 6.96 (1H, s, NH), 3.45 (2H, td, J 6.5, 
2.8, 6–H), 2.60 (2H, t, J 6.5, 5–H); 13C (126 MHz, methylene 
chloride-d2): δ = 188.56, 163.72, 75.41, 37.36, 36.68; Rf 0.08 
(Et2O); IR νmax (film)/cm-1 3183, 3045, 2905, 2150, 1650, 1461, 
1416, 1347, 1291, 1039; HRMS (ESI) Molecular ion not found. 
Spectroscopic data matches literature.26  
2-Diazoindan-1,3-dione, 12c 
By general procedure C1, to 1,3-indandione (3.4 mmol, 500 mg) 
and p-ABSA (5.1 mmol, 1.22 g) in MeCN (0.12 M, 30 mL) was 
added NEt3 (0.57 mL, 4.08 mmol) dropwise at -10 °C and 
allowed to react at room temperature for 1 h. The crude 
material was purified by column chromatography eluting with 
CH2Cl2 to give the diazo compound as a yellow amorphous solid 
(446 mg, 76%); 1H (501 MHz, methylene chloride-d2): δ = 7.84-
7.79 (2 H, m, 4– and 7–H), 7.78-7.74 (2 H, m, 5– and 6–H); 13C 
 
 
(126 MHz, Methylene Chloride-d2): δ = 182.39, 137.57, 135.17, 
122.88, 70.39; Rf 0.40 (CH2Cl2); IR νmax (neat)/cm-1 2119, 1688, 
1594, 1350, 1329, 1265, 1188, 738, 709; HRMS (ESI) Molecular 
ion not found. Spectroscopic data matches literature.27 
5-Diazo-2,2-dimethyl-1,3-dioxane-4,6-dione, 12d 
By general procedure C1, to 2,2-dimethyl-1,3-dioxane-4,6-dione 
(3.5 mmol, 500 mg) and p-ABSA (5.25 mmol, 1.26 g) in MeCN 
(0.12 M, 30 mL) was added NEt3 (4.20 mmol, 0.58 mL) dropwise 
at -10 °C and allowed to react at room temperature for 30 min. 
The crude material was purified by column chromatography 
eluting with CH2Cl2 to give the diazo compound as a colourless 
amorphous solid (541 mg, 91%); 1H (501 MHz, methylene 
chloride-d2): δ = 1.76 (6H, s, dimethyl); 13C (126 MHz, methylene 
chloride-d2): δ = 158.65, 107.40, 64.39, 26.95; Rf 0.38 (CH2Cl2); IR νmax (neat)/cm-1 2175, 1706, 1308, 1296, 1191, 1165, 1026, 
977, 905; HRMS (ESI). Molecular ion not found. Spectroscopic 
data matches literature.28 
N-(3-Chloro-4-methoxyphenyl)-2-diazo-N-methyl-3-
oxobutanamide, 13a 
By general procedure C2, 3-chloro-4-methoxy-N-methylaniline 
(3.5 mmol, 600 mg) in toluene (1.4 M, 2.5 mL) and 2,2,6-
trimethyl-1,3-dioxin-4-one (3.85 mmol, 510 µL) were reacted under μW irradiation at 110 °C for 1.5 h. The crude material was 
purified by column chromatography eluting with CH2Cl2–MeOH 
(98:2) to give the butanamide (840 mg, 94%). By general 
procedure C3, to the butanamide (840 mg, 3.28 mmol) and p-
ABSA (1.20 g, 4.92 mmol) in MeCN (0.12 M, 28 mL) was added 
NEt3 (0.55 mL, 3.94 mmol) to give a crude material which was 
purified by column chromatography eluting with CH2Cl2–Et2O 
(9:1) to give the diazo compound as a light yellow, low melting 
solid (412 mg, 45%); 1H (501 MHz, methylene chloride-d2): δ =  
7.27 (1H, d, J 2.6, aryl 2–H), 7.12 (1H, dd, J 8.7, 2.6, aryl 6–H), 
6.97 (1H, d, J 8.7, aryl 5–H), 3.91 (3H, s, methoxy), 3.29 (3H, s, N-
methyl), 2.44 (3H, s, methyl); 13C (126 MHz, methylene chloride-
d2): δ = 191.62, 161.06, 155.10, 136.47, 128.71, 126.59, 123.71, 
113.19, 73.95, 56.81, 38.74, 28.57; Rf 0.43 (CH2Cl2–Et2O, 9:1); IR νmax (film)/cm-1 3360, 2110, 1642, 1499, 1361, 1265, 1247, 
1062, 1020; HRMS (ESI) C12H12ClN3O3 requires [M+Na]+, 
calculated 304.0460, found 304.0456. 
N‐(4‐Chlorophenyl)‐2‐diazo‐N‐methyl‐3‐oxobutanamide, 
13b 
By general procedure C2, 4-Chloro-N-methyl aniline (8.3 mmol, 
1.00 mL) in toluene (8 mL) and 2,2,6-trimethyl-1,3-dioxin-4-on 
(12.5 mmol, 1.66 mL) were reacted under μW irradiation at 110 
oC for 30 min. The crude material, p-ABSA (9.1 mmol, 2.20 g) 
and triethylamine (1.30 mL, 9.1 mmol) were then added and the 
reaction allowed to warm to room temperature over 16 hours. A 
white precipitate formed, which was removed by filtration, and 
the solvent then removed under reduced pressure to give a dark 
red oil which was purified by column chromatography eluting 
CH2Cl2, then CH2Cl2–Et2O (9:1) to give the diazo compound 13b 
as a yellow oil that solidified on standing (1.34 g, 64%); 1H (400 
MHz, CDCl3): δ = 7.39 (2H, d, J 8.7), 7.14 (2H, d, J 8.7), 3.34 (3H, 
s), 2.46 (3H, s); 13C (100 MHz, CDCl3): δ = 191.4, 161.1, 157.1, 
141.7, 133.9, 130.6, 127.5, 38.6, 28.5; IR νmax (CH2Cl2 film)/cm-1 
2184 (diazo), 1636, 1590, 1487, 1356; Rf 0.10 (CH2Cl2); HRMS 




By general procedure C2, to 6-chloro-1,2,3,4-
tetrahydroquinoline (3.0 mmol, 500 mg) in toluene (1 M, 3.00 
mL) was added 2,2,6-trimethyl-1,3-dioxin-4-one (3.3 mmol, 440 
µL) and the solution was reacted under μW irradiation at 110 °C 
for 1.5 hr. The crude product was purified by silica column 
chromatography eluting with CH2Cl2–Et2O (9:1) to give the 
butanamide (744 mg, 99%). By general procedure C3, to the 
butanamide (0.70 g, 2.78 mmol) and p-ABSA (1.00 g, 4.17 mmol) 
in MeCN (0.12 M, 23 mL) was added NEt3 (0.46 mL, 3.34 mmol). 
After 4h, the crude material was purified by column 
chromatography eluting with CH2Cl2–Et2O (9:1) to give the diazo 
compound as a light yellow, low melting solid (439 mg, 57%); 1H 
(501 MHz, methanol-d4): δ = 7.32 (1H, d, J 8.6, quinolinyl 5–H), 
7.25 (1H, d, J 2.5, quinolinyl 8–H), 7.17 (1 H, dd, J 8.6, 2.5, 
quinolinyl 7–H), 3.75 (2H, t, J 6.5, quinolinyl 2–H), 2.74 (2H, t, J 
6.5, quinolinyl 4–H), 2.32 (3H, s, methyl), 1.98 (2H, p, J 6.5, 
quinolinyl 3–H); 13C (126 MHz, methanol-d4): δ = 191.12, 
162.46, 138.42, 135.83, 131.68, 129.70, 127.87, 124.85, 77.41, 
45.90, 27.56, 27.44, 24.76; Rf 0.43 (CH2Cl2–Et2O, 9:1); IR νmax 
(film)/cm-1 2950, 2891, 2107, 1632, 1484, 1345, 1255, 1197, 
1170, 1090, 946; HRMS (ESI) C13H12ClN3O2 requires [M+Na]+, 
calculated 300.0511, found 300.0508. 
2-Diazo-1-[(2R,6S)-2-allyl-6-phenyl-1,2,3,6-
tetrahydropyridin-1-yl]butane-1,3-dione, 13d 
By general procedure C2, to (2R,6S)-2-allyl-6-phenyl-1,2,3,6-
tetrahydropyridine (996 mg, 5 mmol) the diazo transfer was 
performed for 24 h followed by purification with column 
chromatography, eluting with CH2Cl2 to give the diazo compound 
13d as a yellow oil (0.339 g, 22%); 1H (501 MHz, Acetone-d6): δ 
= 7.33 (2H, d, J 7.9, phenyl 2–H and 6–H), 7.27 (2H, app t, J 7.9, 
phenyl 3–H and 5–H), 7.17 (1H, app t, J 7.9,  phenyl 4–H), 5.87 
(1H, ddt, J 17.1, 10.1 and 7.4, allyl 2–H), 5.76 (1H, dd, J 2.3 and 
10.0, pyridinyl 5–H), 5.69 (1H, dt, J 10.0 and 3.0, pyridinyl 4–H), 
5.21 (1H, d, J 2.3, pyridinyl 6–-H), 5.14 (1H, d, J 17.1, allyl 3–
Htrans), 5.09 (1H, dd, J 10.1 and 2.0, allyl 3–Hcis), 4.29 (1H, m, 
pyridinyl 2–H), 2.83 (1H, m, allyl 1–Ha), 2.62 (1H, m, pyridinyl 
3–Ha), 2.35 (1H, m, pyridinyl 3–Hb), 2.23 (1H, m, allyl 1–Hb), 2.21 
(3H, s, butane 4–H); 13C (75 MHz, Acetone-d6): δ = 189.0, 164.0, 
144.0, 136.4, 130.2, 129.2, 127.5, 127.5, 121.4, 118.5, 76.1, 58.3, 
54.8, 38.8, 29.4, 27.3; Rf 0.14 (CH2Cl2); IR νmax (film)/cm-1 3033, 
2114, 1697, 1655, 1611, 1493, 1449; HRMS (ESI) C18H19N3O2Na 
requires [M+Na]+, calculated 332.1370, found 332.1369. 
2-Diazo-1-{3-oxo-2-azabicyclo[2.2.1]hept-5-en-2-yl}butane-
1,3-dione, 13e 
By general procedure C2, to 2-azabicyclo[2,2,1]hept-5-en-3-one 
(500 mg, 4.6 mmol) the diazo transfer was performed for 24 h, 
followed by purification with column chromatography, eluting with Petrol−EtOAc (7:3), to give the diazo compound 13e as a 
yellow oil (0.29 g, 29%); 1H (400 MHz, CDCl3): δ = 6.91 (1H, dd, J  
5.2 and 2.3, 5–H), 6.48 (1H, dd, J 5.2 and 3.3, 6–H), 4.79 (1H, m, 
4–H), 3.35 (1H, m, 1–H), 2.30 (3H, s, methyl–H), 2.21 (1H, dt, J 
8.8 and 1.4, 7–Ha), 2.11 (1H, dt, J 8.8 and 1.3, 7–Hb); 13C (400 
MHz, CDCl3): δ = 189.8, 175.6, 160.3, 140.6, 136.1, 62.2, 53.7, 
53.0, 28.4; Rf 0.27 (Petrol−EtOAc, 7:3); IR νmax (film)/cm-1 2955, 
2139, 1745, 1651, 1302; HRMS (ESI) C10H9N3NaO3 requires 





By general procedure C2, with 4-isopropylpyrrolidin-2-one (500 
mg, 3.93 mmol) the diazo transfer was performed for 24 h 
followed by purification with column chromatography, eluting 
with CH2Cl2−MeOH (99:1) to give the diazo compound 13f as a 
yellow amorphous solid (0.376 g, 40%); 1H (400 MHz, Acetone-
d6): δ = 3.89 (1H, dd, J 10.8 and 7.8, pyrrolidinyl 5–Ha), 3.51 (1H, 
dd, J 10.8 and 9.2, pyrrolidinyl 5–Hb), 2.64 (1H, dd, J 17.4 and 
8.3, pyrrolidinyl 3–Ha), 2.42 (1H, dd, J 17.4 and 8.3, pyrrolidinyl 
3–Hb), 2.39 (3H, s, butane 4–H), 2.14 (1H, td, J 17.4 and 8.3, 
pyrrolidinyl 4–H), 1.68 (1H, m, isopropyl–H), 0.96 (6H, d, J 6.7, 
isopropyl–H); 13C (101 MHz, Acetone-d6): δ = 190.2, 174.5, 
160.6, 79.2, 51.0, 38.8, 38.1, 32.6, 28.6, 20.7, 20.3; Rf 0.24 
(CH2Cl2−MeOH, 99:1); IR νmax (film)/cm-1 2962, 2133, 1732, 
1650, 1316, 1204; HRMS (ESI) C11H15NO3Na requires [M-
N2+Na]+, calculated 232.0944, found 232.0942. 
2-Diazo-1-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]butane-
1,3-dione, 13g 
By general procedure C2, using (4S)-4-phenyl-1,3-oxazolidin-2-
one (1.5 g, 9.2 mmol) with the diazo transfer performed for 24 h 
followed by purification with column chromatography, eluting 
with CH2Cl2 to give the diazo compound 13g as a white 
amorphous solid (1.280 g, 53%); 1H (400 MHz, methylene 
chloride-d2): δ = 7.41 (5H, m, phenyl 2–H, 3–H, 4–H, 5–H and 6-
H), 5.59 (1H, t, J 8.8, oxazolidinyl 4–H), 4.77 (1H, app t, J 8.8, 
oxazolidinyl 5–Ha), 4.25 (1H, app t, J 8.8, oxazolidinyl 5–Hb), 2.37 
(3H, s, butane 4–H); 13C (101 MHz, methylene chloride-d2): δ = 
189.7, 160.0, 153.6, 137.3, 129.6, 129.5, 127.1, 80.0, 70.8, 59.2, 
28.8; Rf 0.17 (CH2Cl2);  IR νmax (film)/cm-1 3058, 2136, 1775, 
1656, 1308, 1207; HRMS (ESI) C13H11NO4Na requires [M-
N2+Na]+, calculated 268.0580, found 268.0577. 
2-Diazo-2-(3,4-dichlorophenyl)-N-methyl-N-
phenylacetamide, 9k 
By general procedure C3 (1 mmol scale), 2-(3,4-
dimethylphenyl)-N-methyl-N-phenylacetamide (293 mg, 1 
mmol) and p-ABSA (264 mg, 1.1mmol) gave  a crude material 
and was purified using column chromatography eluting with 
CH2Cl2–Et2O (9:1) to yield the diazoacetamide 9k as an orange 
oil (252 mg, 79%); Rf 0.67 (Pentane–Et2O, 1:1); 1H (400 MHz, 
(CD3)2CO): δ = 7.63 (1H, d, J 2.3, dichloroPhe 2-H), 7.48 (2H, d, J 
8.5, dichloroPhe 5-H), 7.42 (2H, m, NPhe 3-H, 5-H), 7.34 (2H, m, 
NPhe 2-H, 6-H), 7.28 (1H, m, NPhe 4-H), 7.18 (1H, dd, J 8.5, 2.3, 
dichloroPhe 6-H), 3.38 (3H, s, NMe); 13C (101 MHz, (CD3)2CO): δ 
= 164.2, 145.0, 132.9, 131.4, 130.8, 130.1, 128.9, 127.7, 127.0, 
126.6, 124.6, 112.7, 38.7; HRMS (ESI): C15H12Cl2NO requires [M-
N2+H]+, calculated 292.0296, found 292.0277.  
N,2‐bis(4‐chlorophenyl)‐2‐diazo‐N‐methylacetamide, 9l 
By general procedure C3, N,2‐bis(4‐chlorophenyl)‐N‐
methylacetamide (300 mg, 1.0 mmol) and p-ABSA (269 mg, 1.1 
mmol) gave a viscous orange oil that was purified by flash 
column chromatography eluting with pentane–Et2O (9:1) to give 
the diazo compound 9l as an orange oil (114 mg, 35%); 1H (400 
MHz, Acetone-d6): δ = 7.42-7.39 (2H, m), 7.36-7.30 (6H, m), 3.36 
(3H, s); 13C (101 MHz, (CD3)CO): δ = 164.9, 144.2, 132.7, 131.7, 
130.8, 130.0, 129.7, 128.3, 127.7, 127.2, 38.7; IR νmax (CH2Cl2 
film/cm-1 2066 (diazo), 1635, 1490, 1313; Rf 0.14 (1:1 
Pentane/Et2O). HRMS (ESI): C15H11Cl2N3O requires [M+Na]+, 
calculated 342.0177, found 342.0165. 
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